$152 0.3 0.2%
Last Trade - 9:10pm
| Market Cap | £18.72bn |
| Enterprise Value | £23.63bn |
| Revenue | £175.72bn |
| Position in Universe | 394th / 6362 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Mar | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 179,045 | 190,884 | 198,533 | 208,357 | 214,319 | 231,051 | 238,041 | 250,158 | +5.2% | ||
| +25.6 | +20.8 | +8.2 | -65.7 | +98.9 | -20.6 | +144.6 | +13.9 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2020
|
31st Dec 2021
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
McKesson Corporation is a healthcare supply chain management solution, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through three segments: United States Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions and Medical-Surgical Solutions. The United States Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare related products and provides pharmaceutical solutions to life sciences companies. European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers. Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers.
| Last Annual | March 31st, 2020 |
| Last Interim | June 30th, 2020 |
| Incorporated | July 7, 1994 |
| Public Since | November 10, 1994 |
| No. of Shareholders: | 5,034 |
| No. of Employees: | 80,000 |
| Sector | Consumer Defensives |
| Industry | Food & Drug Retailing |
| Index | S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector), |
| Exchange | New York Stock Exchange |
| Shares in Issue | 162,189,761 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 6555 State Highway 161, IRVING, 75039-2402, United States |
| Web | http://www.mckesson.com |
| Phone | +1 972 4464800 |
| Contact | () |
| Auditors | Deloitte & Touche LLP |
As of 9:10pm, shares in Mckesson are trading at $152, giving the company a market capitalisation of £18.72bn. This share price information is delayed by 15 minutes.
Shares in Mckesson are currently trading at $152 and the price has moved by 9.01% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Mckesson price has moved by -3.76% over the past year.
Of the analysts with advisory recommendations for Mckesson, there are there are currently 5 "buy" , 6 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Mckesson is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Mckesson is scheduled to issue upcoming financial results on the following dates:
The Mckesson dividend yield is 1.07% based on the trailing twelve month period.
Last year, Mckesson paid a total dividend of 1.62, and it currently has a trailing dividend yield of 1.07%. Looking ahead, shares in Mckesson are due to go ex-dividend on 2020-08-31 and the next dividend pay date is 2020-10-01.
Mckesson are due to go ex-dividend on 2020-08-31 and the next dividend pay date is 2020-10-01. The historic dividend yield on Mckesson shares is currently 1.07%.
To buy shares in Mckesson you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Mckesson are currently trading at $152, giving the company a market capitalisation of £18.72bn.
Here are the trading details for Mckesson:
Based on an overall assessment of its quality, value and momentum, Mckesson is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Mckesson are currently priced at $152. At that level they are trading at 21.5% discount to the analyst consensus target price of 0.00.
Analysts covering Mckesson currently have a consensus Earnings Per Share (EPS) forecast of 14.995 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mckesson. Over the past six months, the relative strength of its shares against the market has been -2.21%. At the current price of $152, shares in Mckesson are trading at 4.21% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Mckesson PE ratio based on its reported earnings over the past 12 months is 29.16. The shares are currently trading at $152.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Mckesson's management team is headed by:
Here are the top five shareholders of Mckesson based on the size of their shareholding:
